PL359105A1 - Neurochronne 7-beta-hydroksysteroidy - Google Patents

Neurochronne 7-beta-hydroksysteroidy

Info

Publication number
PL359105A1
PL359105A1 PL01359105A PL35910501A PL359105A1 PL 359105 A1 PL359105 A1 PL 359105A1 PL 01359105 A PL01359105 A PL 01359105A PL 35910501 A PL35910501 A PL 35910501A PL 359105 A1 PL359105 A1 PL 359105A1
Authority
PL
Poland
Prior art keywords
hydroxysteroids
neuroprotective
beta
hydroxy
steroids
Prior art date
Application number
PL01359105A
Other languages
English (en)
Other versions
PL200698B1 (pl
Inventor
Ernst Wülfert
Ashley Ker Pringle
Lars Eric Sundstrom
Original Assignee
Hunter-Fleming Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter-Fleming Limited filed Critical Hunter-Fleming Limited
Publication of PL359105A1 publication Critical patent/PL359105A1/pl
Publication of PL200698B1 publication Critical patent/PL200698B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL359105A 2000-06-29 2001-06-29 Zastosowanie pochodnych 7ß-hydroksysteroidu do wytwarzania leku do ochrony przed uszkodzeniem neuronów PL200698B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0016027A GB2363984A (en) 2000-06-29 2000-06-29 Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
PCT/GB2001/002929 WO2002000224A1 (en) 2000-06-29 2001-06-29 Neuroprotective 7-beta-hydroxysteroids

Publications (2)

Publication Number Publication Date
PL359105A1 true PL359105A1 (pl) 2004-08-23
PL200698B1 PL200698B1 (pl) 2009-01-30

Family

ID=9894710

Family Applications (1)

Application Number Title Priority Date Filing Date
PL359105A PL200698B1 (pl) 2000-06-29 2001-06-29 Zastosowanie pochodnych 7ß-hydroksysteroidu do wytwarzania leku do ochrony przed uszkodzeniem neuronów

Country Status (23)

Country Link
US (2) US20030186953A1 (pl)
EP (1) EP1294381B1 (pl)
JP (1) JP2004501195A (pl)
KR (1) KR100829490B1 (pl)
CN (1) CN100441189C (pl)
AT (1) ATE303152T1 (pl)
AU (2) AU6770501A (pl)
CA (1) CA2414583C (pl)
CY (1) CY1105371T1 (pl)
CZ (1) CZ305306B6 (pl)
DE (1) DE60113112T2 (pl)
DK (1) DK1294381T3 (pl)
ES (1) ES2247141T3 (pl)
GB (1) GB2363984A (pl)
HK (1) HK1052299B (pl)
HU (1) HU229265B1 (pl)
IL (2) IL153540A0 (pl)
NO (1) NO332089B1 (pl)
PL (1) PL200698B1 (pl)
RU (1) RU2258511C2 (pl)
SI (1) SI1294381T1 (pl)
WO (1) WO2002000224A1 (pl)
ZA (1) ZA200210214B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
EP2298315A1 (en) * 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
ZA200704889B (en) * 2004-11-23 2008-09-25 Celgene Corp JNK inhibitors for treatment of CNS injury
DK2792681T3 (en) * 2006-11-21 2017-01-23 Umecrine Ab Use of Pregnancy and Androstan Steroids in the Preparation of a Pharmaceutical Composition for the Treatment of CNS Disorders.
EP2097079B1 (en) * 2006-11-30 2012-06-27 Hunter-Fleming Limited Modulation of prostaglandin/cyclooxygenase metabolic pathways
GB0623971D0 (en) * 2006-11-30 2007-01-10 Hunter Fleming Ltd Modulation of prostaglandin/cyclooxygenase metabolic pathways
CZ2008434A3 (cs) * 2008-07-10 2009-12-09 Ústav organické chemie a biochemie Akademie ved CR, v. v. i. Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
DE102012001361A1 (de) 2012-01-24 2013-07-25 Linde Aktiengesellschaft Verfahren zum Kaltgasspritzen
US20160362442A1 (en) * 2015-06-10 2016-12-15 IronMag Labs Method For DHEA Enanthate Processing

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
ATE283052T1 (de) * 1993-03-09 2004-12-15 Univ Utah Res Found Verwendung von dhea oder dessen derivate zur herstellung eines medikaments zur vorbeugung von progressiver gewebe-nekrose, reperfusionsschädigung, bakterieller translokation und vom atemnotsyndrom bei erwachsenen
ATE284895T1 (de) * 1995-06-06 2005-01-15 Euro Celtique Sa Neuroaktive steroide der androstan- und pregnanreihe
GB2317826B (en) * 1995-08-29 1999-12-15 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
CN1222851A (zh) * 1996-04-09 1999-07-14 英国技术集团国际有限公司 7α－取代的类固醇用于治疗神经精神病、免疫或内分泌疾病的用途
DE69737791D1 (de) * 1996-04-09 2007-07-19 Univ Edinburgh Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen
JP2001500852A (ja) * 1996-08-27 2001-01-23 プレーシス ファーマスーティカルズ インコーポレイテッド Ｄ―アミノ酸を含むβ―アミロイドペプチド凝集のモジュレーター
RU2142802C1 (ru) * 1997-02-13 1999-12-20 Обут Тимофей Александрович Гипотензивное средство
US6544972B1 (en) * 1997-09-25 2003-04-08 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO1999024400A1 (en) * 1997-11-10 1999-05-20 Vyrex Corporation Probucol esters and uses thereof
EP1032397A1 (en) * 1997-11-24 2000-09-06 University Of Florida Research Foundation, Inc. Testosterone inhibitors and use for the protection of neurons
WO1999052532A1 (en) * 1998-04-14 1999-10-21 Pharmadigm, Inc. Method for reducing central nervous system impairment
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
PT1226155E (pt) * 1999-11-02 2007-07-26 Bayer Schering Pharma Ag 18-nor-esteróides como estrogénios selectivamente activos
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone

Also Published As

Publication number Publication date
CA2414583C (en) 2010-08-24
US20100130459A1 (en) 2010-05-27
EP1294381A1 (en) 2003-03-26
ATE303152T1 (de) 2005-09-15
IL153540A0 (en) 2003-07-06
NO20026244L (no) 2003-02-27
HK1052299B (en) 2006-01-27
NO20026244D0 (no) 2002-12-27
EP1294381B1 (en) 2005-08-31
SI1294381T1 (sl) 2006-04-30
CY1105371T1 (el) 2010-04-28
AU6770501A (en) 2002-01-08
GB0016027D0 (en) 2000-08-23
WO2002000224A1 (en) 2002-01-03
ES2247141T3 (es) 2006-03-01
IL153540A (en) 2008-07-08
PL200698B1 (pl) 2009-01-30
AU2001267705B2 (en) 2005-08-18
JP2004501195A (ja) 2004-01-15
HUP0301317A3 (en) 2006-06-28
CN100441189C (zh) 2008-12-10
US20030186953A1 (en) 2003-10-02
HUP0301317A2 (hu) 2003-08-28
DE60113112T2 (de) 2006-07-13
DK1294381T3 (da) 2005-10-31
ZA200210214B (en) 2004-03-17
CZ305306B6 (cs) 2015-07-22
NO332089B1 (no) 2012-06-18
HU229265B1 (en) 2013-10-28
KR20030034112A (ko) 2003-05-01
KR100829490B1 (ko) 2008-05-16
DE60113112D1 (de) 2005-10-06
CN1443071A (zh) 2003-09-17
RU2258511C2 (ru) 2005-08-20
CA2414583A1 (en) 2002-01-03
HK1052299A1 (en) 2003-09-11
GB2363984A (en) 2002-01-16

Similar Documents

Publication Publication Date Title
AU2000259008A1 (en) Flexible circuits with static discharge protection and process for manufacture
AU5208401A (en) 3-nitrogen-6,7-dioxygen steroids and uses related thereto
AU2002246840A1 (en) Extensible and retractable face mask
AU2001283253A1 (en) Radiation protection device
AU2683100A (en) Inflatable protection apparatus
AU7065200A (en) Putting improvement devices and methods
AU6770501A (en) Neuroprotective 7-beta-hydroxysteroids
IL154267A0 (en) Neuroprotective 2-pyridinamine compositions and related methods
IL154617A0 (en) Active equipment protection methods and apparatus
AU3068700A (en) Transportation protection device and method for producing the same
AU6770901A (en) 7-hydroxyepiandrosterone having neuroprotective activity
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001282457A1 (en) Radiation protection device
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU2923800A (en) Protection for use in protecting an elongated member
ZA200203312B (en) Vasopressin antagonist formulation and process.
AU1414101A (en) Neuroprotective agents and methods related thereto
AU2002222093A1 (en) Goggles and masks
TW401929U (en) Device for protecting the chair back screen from being excessively raised up and damaged
GB9901767D0 (en) Panel damage protectors
AU1652201A (en) Device for protection of the buttocks and coccyx
TW471347U (en) Holding and protecting ring
AU2002339110A1 (en) Methods and apparatus for providing fall-arrest protection
HK1053977A (en) Neuroprotective 2-pyridinamine compositions and related methods
AU2002327431A1 (en) Reticle protection and transport